NXTC

6.4504.87%
KG

Kevin G. Shaw

Senior VP & General Counsel

Mr. Kevin G. Shaw is General Counsel and Senior Vice President of NextCure, Inc. from August 2023 and served as its Senior Vice President of Legal Affairs since May 2022 until August 2023. Prior to joining NextCure, Mr. Shaw served as Vice President and Deputy General Counsel at Precigen, Inc., a publicly traded biotechnology and clinical stage cell and gene therapy company (previously known as Intrexon Corporation), which he joined in January 2012. Previously, Mr. Shaw practiced law at the multinational law firm Hogan Lovells from 2000 until December 2011, where he represented both large and small life sciences companies in a range of intellectual property and transactional matters. Mr. Shaw received his juris doctor from the George Washington University Law School and his undergraduate engineering degree in chemical engineering from the University of Pennsylvania.

Positions